BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9584633)

  • 1. [Metastatic involvement of liver in patients with uveal melanoma].
    Brovkina AF; Val'skiĭ VV; Zarubeĭ GD
    Vestn Oftalmol; 1998; 114(1):21-3. PubMed ID: 9584633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy.
    Furdova A; Strmen P; Sramka M
    Bratisl Lek Listy; 2005; 106(12):401-6. PubMed ID: 16642665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of uveal tract melanoma: A comprehensive review.
    Kapoor A; Beniwal V; Beniwal S; Mathur H; Kumar HS
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):65-72. PubMed ID: 26975730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
    Ben Simon GJ; Abulafia A; Pe'er J
    Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
    Bornfeld N; Chauvel P; Sauerwein W; Friedrichs W; Tiburtius T; Wessing A; Foerster MH
    Front Radiat Ther Oncol; 1997; 30():97-110. PubMed ID: 9205890
    [No Abstract]   [Full Text] [Related]  

  • 8. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas.
    Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
    Ophthalmology; 2002 Oct; 109(10):1855-61. PubMed ID: 12359606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
    Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of primary and secondary enucleation for uveal melanoma.
    Pham CM; Custer PL; Couch SM
    Orbit; 2017 Dec; 36(6):422-427. PubMed ID: 28812919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of liver metastases from uveal melanoma.
    Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
    Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas.
    Gass JD
    Arch Ophthalmol; 1985 Jul; 103(7):916-23. PubMed ID: 4015482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches in the management of uveal melanomas.
    Gragoudas ES
    Int Ophthalmol Clin; 1992; 32(2):129-38. PubMed ID: 1577554
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ocular retention in patients with uveal melanoma managed by a multimodality approach].
    García-Alvarez C; Muiños Y; Saornil MA; Almaraz A; López-Lara F; Frutos JM; Muñoz MF
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):145-9. PubMed ID: 19340720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.
    Liu YC; Tsai CC; Lee FL; Lee SM; Kao SC
    Acta Ophthalmol; 2013 Nov; 91(7):e583-4. PubMed ID: 24131706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.